SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Analysts See AstraZeneca 3Q Core EPS at $2.59

Analysts estimated AstraZeneca's third-quarter core EPS at $2.59.

AZN

Related stories